Whistleblower Lawsuit Filed Against Takeda Over Actos
A whistleblower suit filed against the maker of Actos alleges the company consistently downplayed heart failure cases linked to the drug.
Breaking Class Action News & Legal Updates
First Transvaginal Mesh Case Returns $5.5 Million Verdict
A West Virginia jury has returned a landmark $5.5 million verdict to a woman who alleged she was seriously injured by C.R. Bard's Avaulta Plus transvaginal mesh.
Pradaxa Most Dangerous Drug of 2011, Report
The controversial blood-thinning drug Pradaxa is reportedly the medication with the most reports of serious or fatal adverse reactions in 2011.
Bank of America Force-Placed Flood Insurance Suit Can Proceed
A United States District Court judge has ruled a nationwide class action lawsuit alleging Bank of America illegally force-placed flood insurance can proceed.
Stryker Recalls Two Hip Implant Devices
The New Jersey-based medical device maker has voluntarily recalled its Rejuvenate and ABG II modular-neck hip stem implants due to worries of premature device failure.
Suit Says First Community Bank and Trust Manipulated Debit Transactions
A new class action alleges First Community Bank and Trust rearranged the order of consumers' debit card purchases to manipulate overdraft fees for a profit..
DePuy Hip Device Lawsuit Moves Along
The bellwether trial of the class action alleging Johnson and Johnson's DePuy ASR hip implant caused patients serious injuries will begin later this year.
Florida Leads the Nation in Force-Placed Insurance
According to the Sun-Sentinel, Florida was the source of 35% of the country's force-placed insurance in 2011, totaling $1.2 billion from policyholders.
Pfizer Marketed Zoloft to Pregnant Mothers, Says Lawsuit
A new lawsuit alleges drug manufacturer Pfizer marketed the antidepressant Zoloft to pregnant women without revealing the risk of it potentially causing birth defects.
What is the FDA's 510(k) Device Approval Process?
The FDA's complex 501(k) medical device approval process consists of three levels, known as classes, that categorize the risk posed by products before their approval.